Torrent Pharmaceuticals Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun '26 Jun 30, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	-	11,172	5,735	8,351	5,085	3,984
Short-Term Investments	-	3,723	22.8	279	581.6	5.9
Trading Asset Securities	-	8,657	1,122	1,410	1,561	1,840
Cash & Short-Term Investments	23,552	23,552	6,880	10,040	7,228	5,830
Cash Growth	242.34%	242.34%	-31.48%	38.91%	23.98%	-21.01%
Accounts Receivable	-	30,309	18,665	18,443	19,438	16,325
Other Receivables	-	6,485	3,773	3,390	2,844	2,786
Receivables	-	36,846	22,480	21,863	22,300	19,137
Inventory	-	31,382	25,413	22,791	22,296	24,623
Prepaid Expenses	-	981.3	631.1	589.5	666.9	514.6
Restricted Cash	-	152.6	49.3	38.6	48	44.4
Other Current Assets	-	1,017	773.4	793	753.3	2,798
Total Current Assets	-	93,931	56,226	56,115	53,292	52,947
Property, Plant & Equipment	-	53,660	38,229	35,778	34,598	32,469
Long-Term Investments	-	994.1	445.7	332.9	711.1	679.2
Goodwill	-	39,896	3,389	3,380	3,375	2,595
Other Intangible Assets	-	244,636	42,633	45,828	50,895	35,461
Long-Term Deferred Tax Assets	-	6,983	5,942	5,551	5,437	4,937
Other Long-Term Assets	-	2,986	3,000	3,596	1,785	1,894
Total Assets	-	443,120	149,897	150,606	150,119	130,998
Accounts Payable	-	23,576	18,200	20,893	16,788	16,744
Accrued Expenses	-	7,056	4,174	3,784	3,690	3,111
Short-Term Debt	-	29,146	12,973	16,551	18,113	9,620
Current Portion of Long-Term Debt	-	2,325	5,844	6,959	10,360	9,718
Current Portion of Leases	-	371.9	303.7	200.6	183.3	147.3
Current Income Taxes Payable	-	1,209	955.7	1,679	313.1	414.8
Current Unearned Revenue	-	281.9	24.4	50	18.3	114.8
Other Current Liabilities	-	19,468	4,698	4,134	5,007	4,280
Total Current Liabilities	-	83,433	47,172	54,253	54,473	44,151
Long-Term Debt	-	116,512	11,918	16,038	24,962	21,232
Long-Term Leases	-	1,901	1,459	644.6	529.3	368.2
Long-Term Unearned Revenue	-	224	4.6	9.6	14.6	19.6
Pension & Post-Retirement Benefits	-	936.3	813.2	836	788.1	897.5
Long-Term Deferred Tax Liabilities	-	56,700	8,287	6,561	4,019	1,936
Other Long-Term Liabilities	-	7,565	4,338	3,703	3,351	2,865
Total Liabilities	-	267,271	73,991	82,044	88,138	71,469
Common Stock	-	1,692	1,692	1,692	1,692	846.2
Additional Paid-In Capital	-	-	-	-	-	43.4
Retained Earnings	-	86,439	76,307	67,908	61,159	57,739
Comprehensive Income & Other	-	-4,247	-2,092	-1,039	-870.5	900.6
Total Common Equity	83,884	83,884	75,907	68,562	61,981	59,530
Minority Interest	-	91,964	-	-	-	-
Shareholders' Equity	175,848	175,848	75,907	68,562	61,981	59,530
Total Liabilities & Equity	-	443,120	149,897	150,606	150,119	130,998
Total Debt	150,255	150,255	32,496	40,394	54,148	41,086
Net Cash (Debt)	-126,703	-126,703	-25,616	-30,354	-46,921	-35,257
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-363.06	-374.37	-75.69	-89.69	-138.64	-104.17
Filing Date Shares Outstanding	380.63	338.45	338.45	338.45	338.45	338.45
Total Common Shares Outstanding	380.63	338.45	338.45	338.45	338.45	338.45
Working Capital	-	10,498	9,054	1,862	-1,181	8,796
Book Value Per Share	247.85	247.85	224.28	202.58	183.13	175.89
Tangible Book Value	-200,648	-200,648	29,886	19,353	7,711	21,474
Tangible Book Value Per Share	-592.85	-592.85	88.30	57.18	22.78	63.45
Land	-	7,188	6,808	6,804	6,625	6,953
Buildings	-	21,664	15,785	14,910	11,343	11,698
Machinery	-	37,617	30,951	29,168	25,819	25,792
Construction In Progress	-	4,575	3,673	2,808	6,882	5,443